This article explores the challenges in developing ADA assays for immunogenicity studies, including sensitivity, drug tolerance, cross-reactivity, and assay interference.
This article explores ADA assay platforms for immunogenicity studies, comparing ELISA, ECL, SPR, multiplex assays and Gyrolab to support platform selection and reliable assay performance